Approvals/TGA/DBL DOCETAXEL CONCENTRATED INJECTION 160mg/16mL concentrated injection vial

Approved

STANDARD

DBL DOCETAXEL CONCENTRATED INJECTION 160mg/16mL concentrated injection vial

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: cb0c4bc5abbabc45
Product Name: DBL DOCETAXEL CONCENTRATED INJECTION 160mg/16mL concentrated injection vial
Artg Id: 163803
Artg Name: DBL DOCETAXEL CONCENTRATED INJECTION 160mg/16mL concentrated injection vial
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2010-12-06
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/d92ce2df65fd8ce1b54311e1820cfd02.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/1db4e07a6d7755b9ee81805c166c8ad4.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 31, 2025

Approval ID

cb0c4bc5abbabc45

Type

Standard